Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen
- PMID: 2981408
- DOI: 10.1056/NEJM198501313120503
Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen
Abstract
We assessed the presence of hepatitis B virus (HBV) DNA in liver or serum samples from 134 patients with hepatitis B surface antigen (HBsAg)-negative chronic liver disease, including 20 with hepatocellular carcinoma. HBV DNA sequences were detected in 52 of the 88 liver samples (59 per cent), including 17 of the 20 samples from patients with hepatocellular carcinoma. Presumably "replicative forms" of HBV DNA were detected in only 5 of the 88 liver samples, 3 of which were from patients with no serologic marker for HBV. In most of the liver samples the DNA patterns were consistent with the presence of HBV or a closely related virus. Of the 105 serum samples tested, HBV DNA sequences were identified in 10 (9.5 per cent), 6 of which had no HBV serologic marker. Moreover, HBsAg-associated determinants were detected in 5 of 17 patients who were positive for HBV DNA and in none of 14 patients who were negative. This study demonstrates the high frequency of HBsAg-negative HBV DNA-positive viral infection of the liver and suggests that multiplication of HBV may occur in the absence of any conventional serologic marker for HBV.
Similar articles
-
HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.J Viral Hepat. 2005 May;12(3):325-9. doi: 10.1111/j.1365-2893.2005.00586.x. J Viral Hepat. 2005. PMID: 15850475
-
Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.J Med Virol. 2003 May;70(1):20-6. doi: 10.1002/jmv.10353. J Med Virol. 2003. PMID: 12629639
-
Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens.N Engl J Med. 1981 Oct 29;305(18):1067-73. doi: 10.1056/NEJM198110293051807. N Engl J Med. 1981. PMID: 6268980
-
Hepatitis B virus chronic liver disease and hepatocellular carcinoma.Postgrad Med J. 1987;63 Suppl 2(737):13-9. Postgrad Med J. 1987. PMID: 2825153 Free PMC article. Review.
-
Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease.Antiviral Res. 2001 Nov;52(2):117-23. doi: 10.1016/s0166-3542(01)00176-0. Antiviral Res. 2001. PMID: 11672821 Review.
Cited by
-
Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure.World J Hepatol. 2015 May 8;7(7):954-67. doi: 10.4254/wjh.v7.i7.954. World J Hepatol. 2015. PMID: 25954478 Free PMC article. Review.
-
Hepatocellular carcinoma. A worldwide problem and the major risk factors.Dig Dis Sci. 1991 Jul;36(7):962-72. doi: 10.1007/BF01297149. Dig Dis Sci. 1991. PMID: 1649041 Review.
-
Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection.Saudi J Gastroenterol. 2009 Oct-Dec;15(4):220-4. doi: 10.4103/1319-3767.56089. Saudi J Gastroenterol. 2009. PMID: 19794265 Free PMC article. Review.
-
Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease.Br J Cancer. 1998 Jun;77(11):2028-31. doi: 10.1038/bjc.1998.337. Br J Cancer. 1998. PMID: 9667687 Free PMC article.
-
Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus.Proc Natl Acad Sci U S A. 1992 May 1;89(9):3874-8. doi: 10.1073/pnas.89.9.3874. Proc Natl Acad Sci U S A. 1992. PMID: 1570307 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical